The U.S. Food and Drug Administration approved Zepzelca (lurbinectedin) in combination with atezolizumab as a maintenance treatment for adults with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE